MPC THERAPEUTICS
MPC Therapeutics develops a novel class of compounds with application in Immunotherapy and Metabolic diseases
MPC THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
2018-11-11
Address:
Plan-les-ouates, Geneve, Switzerland
Country:
Switzerland
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.07 M USD
Similar Organizations
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
InnoSuisse
InnoSuisse investment in Grant - MPC Therapeutics
KICK Ventures
KICK Ventures investment in Grant - MPC Therapeutics
Eclosion SA
Eclosion SA investment in Convertible Note - MPC Therapeutics
More informations about "MPC Therapeutics"
MPC Therapeutics - MitoWorld - MitochondriaWorld
MPC Therapeutics is a biotechnology company founded on the belief that mitochondria, small organelles at the core of the cell’s metabolism, represent untapped therapeutic targets. Using our deep understanding of mitochondrial …See details»
MPC Therapeutics - Funding, Financials, Valuation & Investors
MPC Therapeutics develops a class of compounds with applications in immunotherapy and metabolic diseases. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ...See details»
MPC Therapeutics - LinkedIn
MPC Therapeutics Biotechnology Research Plan-les-Ouates, Geneva 989 followers Biotech company focused on cellular rejuvenation to fight cancer & degenerative pathologies.See details»
MPC Therapeutics - PitchBook
MPC Therapeutics General Information Description. Operator of a pre-clinical stage biotechnology company intended to improve the performance of T-cell therapies. The company develops …See details»
MPC Therapeutics SA - Drug pipelines, Patents, Clinical trials
GENEVA--( BUSINESS WIRE )--MPC Therapeutics (MPC Tx), a Swiss biotechnology company focused on metabolism and rejuvenation , today announced the closing of its CHF 1.5 million …See details»
MPC Therapeutics - VentureRadar
MPC Therapeutics aims to increase the effectiveness of Cancer Immunotherapies, by developing small molecules specifically targeting the Mitochondria. Our vision is that modifying energy …See details»
A CHF 1.5M seed-funding round for MPC Therapeutics …
Dec 12, 2024 MPC Therapeutics (MPC Tx), is a Swiss biotechnology company based in Geneva, focusing on metabolism and cellular rejuvenation. The company announced the closing of its CHF 1.5 million seed-funding round. …See details»
MPC Therapeutics SA - Venture Kick
Jun 11, 2023 MPC Therapeutics specializes in mitochondrial research and is developing innovative solutions to rejuvenate tissues. The company's current focus is on the development …See details»
MPC Therapeutics SA Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for MPC Therapeutics SA of Genève, GENÈVE. Get the latest business insights from Dun & Bradstreet.See details»
MPC Therapeutics SA - startup.ch
MPC Therapeutics specializes in mitochondrial research and is developing innovative solutions to rejuvenate tissues. The company's current focus is on the development of small molecules targeting the Mitochondrial Pyruvate Carrier …See details»
MPC Therapeutics raises CHF 1.5 million in a seed round to …
Oct 1, 2023 Venture Kick alum MPC Therapeutics (MPC Tx), a Swiss biotechnology company focused on metabolism and rejuvenation, today announced the closing of its seed funding …See details»
MPC Therapeutics Company Profile - Office Locations ... - Craft
MPC Therapeutics has 5 employees at their 1 location and $1.63 m in total funding,. See insights on MPC Therapeutics including office locations, competitors, revenue, financials, executives, …See details»
MPC Therapeutics - Products, Competitors, Financials, Employees ...
TheraPPi Bioscience, MPC Therapeutics SA and dEEgtal awarded by the FIF - BioAlps. Nov 17, 2023. TheraPPi Bioscience, MPC Therapeutics SA and dEEgtal awarded by the FIF …See details»
MPC Therapeutics SA - Swiss Biotech
Genevant brings world-class delivery platforms that include best-in-class lipid nanoparticle (LNP) technology and next generation ligand conjugate technology, the industry’s most robust and …See details»
TheraPPi Bioscience, MPC Therapeutics SA and dEEgtal awarded
Nov 29, 2024 MPC Therapeutics SA, a spin-off from the University of Geneva based in Plan-les-Ouates, is working to combat cancer and degenerative diseases by improving the efficacy of …See details»
MPC Therapeutics closes CHF 1.5M seed-funding round
Jan 31, 2023 MPC Therapeutics closes CHF 1.5M seed-funding round. MPC Therapeutics, a biotechnology spin-off of UNIGE focused on metabolism and cellular rejuvenation, announced …See details»
Raphael Martinou - Co-founder & CEO @ MPC Therapeutics
Primary Organization . MPC Therapeutics . Location Plan-les-ouates, Geneve, Switzerland; Regions Europe, Middle East, and Africa (EMEA) Gender Male; LinkedIn View on LinkedIn ; …See details»
A novel mitochondrial pyruvate carrier inhibitor drives stem cell …
M.W. and J.-C.M. are part of the management team at MPC Therapeutics, a Geneva-based start-up that develops MITO-66. D.M. and P.R. are members of the scientific advisory board at …See details»
CAMP4 Therapeutics Reports Positive Safety Data from CMP-CPS …
21 hours ago CAMP4 Therapeutics reports positive Phase 1 trial results for CMP-CPS-001, advances Parkinson's disease program, ... the Company’s ability to grow the Company’s …See details»
NorthStar Medical Radioisotopes and YAP Therapeutics Enter into ...
5 hours ago BELOIT, Wis. & LAGUNA HILLS, Calif., January 08, 2025--NorthStar Medical Radioisotopes, LLC and YAP Therapeutics, Inc. have entered into a collaboration agreement …See details»